Conclusion
Given the reported ES infection rate of 4.1 per 1000 catheter days and CRBSI of 4.5 per 1000 catheter days, in this ongoing study, preliminary results demonstrate that the use of Preventogen liquid polymer as a dressing for THDC was safe with no documented ES infections and no cases of CRBSI over 4090 catheter days. Further study is ongoing. Use of this polymer can decrease the incidence of wound infection and the need for systemic antibiotics who’s use can contribute to antibiotic resistance and other complications related to antibiotic therapy. Healing these complex wounds with fewer systemic antibiotics in a shorter span of time can save lives and limbs.
